mTOR inhibition overcomes docetaxel chemoresistance in prostate cancer cell and mouse models through downregulation of sphingosine kinase 1Hassan Alshaker, Dmitri Pchejetski, Q. Wang et al.|European Journal of Cancer|2016Cited by 0